Clinical Trials
152 trialsPost-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSense® Cryoablation (ChoICE Trial)
IceCure Medical Ltd.
NIGHT-SCAN
Assistance Publique - Hôpitaux de Paris
riboADHERE
Institute of Oncology Ljubljana
Wearable Device Tracked Recovery From Autologous Breast Reconstructive Surgery
M.D. Anderson Cancer Center
A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer
Memorial Sloan Kettering Cancer Center
PREHAB KINELGD
Institut du Cancer de Montpellier - Val d'Aurelle
Collection of CSF Samples From Participants With Metastatic Triple Negative Breast Cancer (TNBC) and HER2+ Breast Cancer With no Prior History Nor Active Radiographically Detectable Brain Metastases
National Institutes of Health Clinical Center (CC)
Late Scan Time-point Optimalisation of 18F-Fluoroestradiol for the Large Field-of-view (LAFOV) PET/CT Scanner.
University Medical Center Groningen
Super-Resolution Ultrasound Imaging for Assessing Response to Neoadjuvant Chemotherapy in Breast Cancer
Anhui Provincial Cancer Hospital
Fast-Her: Fasting Effects on Breast Cancer Treatment
University of Minnesota
Strategies to Decentralize Breast Ultrasound in Rwanda
Brigham and Women's Hospital
Trastuzumab Deruxtecan and Lovastatin in HER2-low and Ultralow Advanced or Metastatic Breast Cancer
Washington University School of Medicine
Overcoming Racial Disparities in Screening Mammography
Washington University School of Medicine
IMPACT
Lumicell, Inc.
A Phase ll, Interventional, Single-arm Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib and Fulvestrant in Chinese Patients With PIK3CA-mutant, HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer.
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
TD-DASHER-01
Tang-Du Hospital
Studying the Workflow of the American College of Surgeons Geriatric Surgery Program to Improve Clinical Outcomes in Older Adults Undergoing Surgery at the James Cancer Hospital
Ohio State University Comprehensive Cancer Center
HYPNO-AJA2
Institut Bergonié
REFLEX
University of Castilla-La Mancha
Creating Opportunities For Personal Empowerment (COPE) In Women With Breast Cancer During First-Line Therapy: A Pilot Randomized Controlled Trial
M.D. Anderson Cancer Center
IFOCOS
Fudan University
DOTA-STR-17126
Integrated Haematology and Oncology Network
A Study to Estimate Effect of Formulation and Food on Relative Bioavailability of HRS-6209 in Healthy Participants
Jiangsu HengRui Medicine Co., Ltd.
PCDM
University of Rochester
STREAK
University Hospital, Basel, Switzerland
preEMBER
Eli Lilly and Company
A Study Evaluating Adherence, Tolerability, and Patient Reported Outcomes of Giredestrant in Participants With ER+/HER2- Early Breast Cancer Who Are Intolerant to Adjuvant Aromatase Inhibitor Therapy (novERA Breast Cancer)
Genentech, Inc.
AROVAGUE
Institut Cancerologie de l'Ouest
ARTEMIS
Institut Cancerologie de l'Ouest
A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of HLX319 vs. EU-Phesgo® in the Neoadjuvant Therapy of HER2-Positive Early or Locally Advanced Breast Cancer
Shanghai Henlius Biotech
NEURO-BREAC-02
University Hospital Schleswig-Holstein
Research on the Whole-Process Intelligent Diagnosis and Treatment of Digital Breast Tomosynthesis Based on Deep Learning
Yunnan Cancer Hospital
Real-Time IGRT
University of Sydney
PSID
Washington University School of Medicine
Adjuvant Endocrine Therapy Adherence Intervention Pilot in Rwanda
Dana-Farber Cancer Institute
BEYOND
AstraZeneca
Non-Contrast Breast MRI Diagnosis and Risk Stratification Using DWI-Generated Synthetic Contrast Enhancement
Peking University People's Hospital
Cancer
Federal University of Maranhao
ADES
Peking University Cancer Hospital & Institute
Real-world Study of Pyrotinib-containing Regimens of Advanced HER2-positive Breast Cancer
Peking University People's Hospital
Self-management Interventions to Reduce Cardiovascular Risks in Breast Cancer Survivors
University of Southern Queensland
BRE-06: Study to Increase Tolerance to Aromatase Inhibitors for Patients With Early-Stage Hormone Receptor Positive Breast Cancer Who Developed Hypoactive Sexual Desire Disorder
University of Illinois at Chicago
Ultrasound Monitoring of Clipped Lymph Nodes to Predict Axillary Response After Chemotherapy in Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
HER2-positive Metastatic Breast Cancer in Kazakhstan
AstraZeneca
Clinical Application of Vagus Nerve Stimulation Combined With Immunoregulatory T Cells in Alleviating Aromatase Inhibitor-Induced Pain
Peking University People's Hospital
EXPRESSO
IRCCS San Raffaele
DETE-BR
West China Hospital
GATHER
Centre Henri Becquerel
B-BIT
Seoul St. Mary's Hospital
5T4 Targeting Nanobody Probe for PET Imaging in Solid Tumors
Peking University Cancer Hospital & Institute